Modalis Therapeutics Revenue

Revenue

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

4.90B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	-	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	40.00M	39.00M	3,900.00%
Dec 31, 2021	1.00M	-341.00M	-99.71%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
MedRx	128.00M
Nippon Chemiphar	32.52B
Cyfuse Biomedical K.K.	230.00M
WDB coco	4.98B
SymBio Pharmaceuticals	1.31B
Solasia Pharma K.K.	429.00M
Morishita Jintan	12.87B
Wakamoto Pharmaceutical	9.43B

Revenue Rankings

Modalis Therapeutics News

9 months ago - SOLVE FSHD and Modalis Announce Strategic Collaboration to Develop an Innovative CRISPR-Based Epigenome Editing Treatment for Facioscapulohumeral Muscular Dystrophy - Financial Post

More News